Results 91 to 100 of about 447,491 (216)
A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas
, 2013 Andrew J. Wagner, Rashmi Chugh, Lee S. Rosen, Jeffrey A. Morgan, Suzanne George, Michael A. Gordon, Joi Dunbar, Emmanuel Normant, David Grayzel, George D. Demetri +9 moreopenalex +1 more sourceIMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib plus nivolumab in advanced soft tissue and bone sarcomas: Results of the phase II- soft-tissue sarcoma cohort
, 2019 Javier Martín‐Broto, Nadia Hindi, Giovanni Grignani, Javier Martínez‐Trufero, Andrés Redondo, Claudia Valverde, Antonio López–Pousa, Silvia Stacchiotti, Emanuela Palmerini, Enrique de Álava, David S. Moura, Herminia Pérez Vega, Paola Collini, Irene Otero, P. Ledesma, Emanuela Marchesi, Lorenzo D’Ambrosio, José A. López-Martín +17 moreopenalex +1 more sourceEffect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial
JAMA Oncology, 2018 R. Issels, L. Lindner, J. Verweij, R. Wessalowski, P. Reichardt, P. Wust, P. Ghadjar, P. Hohenberger, M. Angele, C. Salat, Ž. Vujašković, S. Daugaard, O. Mella, U. Mansmann, H. Dürr, T. Knösel, S. Abdel-Rahman, Michael Schmidt, W. Hiddemann, K. Jauch, C. Belka, A. Gronchi +21 moresemanticscholar +1 more sourceProspective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte‐macrophage–colony stimulating factor in patients with soft tissue or bone sarcoma [PDF]
, 2000 Dìlek Dìnçol, Mustafa Samur, Ali Pamir, Orhan Şencan, Hakan Akbulut, Bülent Yalçın, Handan Onur, Ahmet Demirkazık, Filiz Çay Şenler, Fikri İçlı +9 moreopenalex +1 more source
